Approvals/TGA/SEEBRI BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister

Approved

STANDARD

SEEBRI BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister

Approval Id: 69f44768d2ed9c82
Product Name: SEEBRI BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister
Artg Id: 191517
Artg Name: SEEBRI BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2012-11-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a9f3fbd18c899afa28804c55d255dc40.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/889a2929807bbc8ee64d7c50ae81a2ad.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

69f44768d2ed9c82

Type

Standard